OMCL | tickerfilter.com

Fundamental analysis

11%

Profitability 2%

Dept financing 47%

Liquidity 31%

Performance 5%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.96%

1 Month

-6.01%

3 Months

1.53%

6 Months

62.28%

1 Year

10.15%

2 Year

-10.82%

Key data

Stock price

$43.16

P/E Ratio

-98.53

DAY RANGE

$42.75 - $44.10

EPS

-$0.46

52 WEEK RANGE

$25.95 - $55.74

52 WEEK CHANGE

$12.65

MARKET CAP

2.046 B

YIELD

N/A

SHARES OUTSTANDING

45.994 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

10/31/2024

BETA

0.40

PUBLIC FLOAT

AVERAGE 10 VOLUME

$812,146

AVERAGE 30 VOLUME

$592,139

Company detail

CEO: Randall A. Lipps
Region: US
Website: omnicell.com
Employees: 3,800
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system. It also provides central pharmacy automation solutions, including automated storage and retrieval systems; IV compounding robots and workflow management systems.

OMCL - OMNICELL, INC.